Cargando…

Adherence to Sars-CoV2 vaccination in hematological patients

BACKGROUND: SARS-CoV2 vaccination efficiently prevents severe COVID-19, although hematological patients, particularly under therapy, respond less well. Besides vaccine efficacy, adherence to vaccination is essential for ensuring adequate protection of this vulnerable population. METHODS: We evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narinx, Justine, Houbiers, Margaux, Seidel, Laurence, Beguin, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588907/ https://www.ncbi.nlm.nih.gov/pubmed/36300128 http://dx.doi.org/10.3389/fimmu.2022.994311

Ejemplares similares

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
por: Baron, Frédéric, et al.
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
por: Pascale, Sara Pasquina, et al.
Publicado: (2022)

Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments
por: Pfannes, Roald, et al.
Publicado: (2023)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)
por: Stebbings, Richard, et al.
Publicado: (2022)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies
por: Bergamaschi, Cristina, et al.
Publicado: (2022)

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
por: Alturki, Sana O., et al.
Publicado: (2020)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022)

SARS-CoV-2 epitopes inform future vaccination strategies
por: Shafqat, Areez, et al.
Publicado: (2022)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis
por: Gagelmann, Nico, et al.
Publicado: (2021)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial
por: Usmani, Salman Sadullah, et al.
Publicado: (2020)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
por: Graninger, Marianne, et al.
Publicado: (2022)

Serum Free Zinc Is Associated With Vaccination Response to SARS-CoV-2
por: Chillon, Thilo Samson, et al.
Publicado: (2022)

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
por: Jonny, Jonny, et al.
Publicado: (2022)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023)

Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults
por: Castro, Vitória Tavares, et al.
Publicado: (2023)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort
por: Zhang, Shihan, et al.
Publicado: (2022)

Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers
por: Huynen, Pascale, et al.
Publicado: (2022)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
por: Flanagan, Katie L., et al.
Publicado: (2020)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development
por: Baay, Marc, et al.
Publicado: (2021)

IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant
por: Bekele, Yonas, et al.
Publicado: (2021)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2020)

Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens
por: Vojdani, Aristo, et al.
Publicado: (2022)

The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review
por: Xie, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_53rhmj1fu8jqro2bj89m7r0qhh